Trina Racine

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial

Glenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten et autres

ca, fr, gb (code pays fourni par la source)

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial

Glenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten et autres

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial

Glenn Hamonic, Supriya Arora, Ravendra Garg, Erin Scruten et autres

Efficient design and production of glycosylated PEDV spike S1 protein

Eva-Maria Uhlemann, Rinku Patel, Brittany Thivierge, Glenn Hamonic et autres

ca (code pays fourni par la source)

What’s new and what’s next for vaccines in 2026?

Trina Racine, Cleo Kontoravdi, Isis Kanevsky, Jeffrey Ulmer et autres

fr, gb, us, in (code pays fourni par la source)

Fusion protein pan-sarbecovirus vaccines elicit broadly protective immune responses targeting Clade 1a, 1b, and 3 sarbecoviruses

Alyson A. Kelvin, Matthew B. Rogers, Zahed Katooni, Eva‐Maria Uhlemann et autres

ca, us, fr (code pays fourni par la source)

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial

Glenn Hamonic, Élodie Pastural, Supriya Arora, J. Lew et autres

ca, ch (code pays fourni par la source)

Safety and Immunogenicity of Covac-2, a Sepivac Swe™ Adjuvanted Sars-Cov-2 Recombinant Protein Vaccine in Healthy Adults; a Randomized Controlled First-in-Human Dose-Escalation Trial

Glenn Hamonic, Élodie Pastural, Supriya Arora, J. Lew et autres

ca, fr, gb (code pays fourni par la source)

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern

Ravendra Garg, Qiang Liu, Jill van Kessel, Akarin Asavajaru et autres

ca (code pays fourni par la source)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques

Alice Berger, Jannie Pedersen, Monika M. Kowatsch, Florine E. M. Scholte et autres

ca, us (code pays fourni par la source)

Efficacy of a Stable Broadly Protective Subunit Vaccine Platform Against Sars-Cov-2 Variants of Concern

Ravendra Garg, Qiang Liu, Jill van Kessel, Akarin Asavajaru et autres

ca, fr (code pays fourni par la source)

Safety and Immunogenicity of Covac-2, a Sepivac Swe™ Adjuvanted Sars-Cov-2 Recombinant Protein Vaccine in Healthy Adults; a Randomized Controlled First-in-Human Dose-Escalation Trial

Trina Racine, Glenn Hamonic, Élodie Pastural, Supriya Arora et autres

ca, fr, gb (code pays fourni par la source)